STATE STREET CORP - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$60,515
-4.6%
85,2320.0%0.00%
Q1 2023$63,430
-48.7%
85,232
-50.0%
0.00%
Q4 2022$123,706
+49.0%
170,464
+100.0%
0.00%
Q3 2022$83,000
-51.7%
85,232
-5.2%
0.00%
Q2 2022$172,000
-92.2%
89,932
-79.7%
0.00%
Q1 2022$2,203,000
-24.1%
443,269
+15.3%
0.00%
Q4 2021$2,902,000
-4.3%
384,358
+0.2%
0.00%
Q3 2021$3,031,000
-83.5%
383,724
-71.1%
0.00%
-100.0%
Q2 2021$18,424,000
+330.3%
1,328,368
+549.0%
0.00%
Q1 2021$4,282,000
+50.7%
204,667
+19.7%
0.00%
Q4 2020$2,841,000
-5.5%
171,027
-3.3%
0.00%
Q3 2020$3,006,000
+7.2%
176,918
+4.8%
0.00%
Q2 2020$2,803,000
+66.3%
168,876
+16.0%
0.00%
Q1 2020$1,686,000
-8.0%
145,608
+17.5%
0.00%
Q4 2019$1,832,000
+25.1%
123,887
+15.5%
0.00%
Q3 2019$1,465,000
+35.5%
107,227
+28.9%
0.00%
Q2 2019$1,081,00083,1630.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$2,335,9571.93%
MPM ASSET MANAGEMENT LLC 3,131,388$2,329,7530.97%
MPM BioImpact LLC 3,196,707$2,378,3500.62%
Lion Point Capital, LP 169,283$125,9800.05%
Artal Group S.A. 1,000,000$7440.04%
Cormorant Asset Management, LP 540,600$4020.03%
KENNEDY CAPITAL MANAGEMENT LLC 529,934$394,3770.01%
Orbimed Advisors 621,218$462,3100.01%
Tekla Capital Management LLC 259,910$193,4250.01%
CM WEALTH ADVISORS LLC 50,354$290.01%
View complete list of HARPOON THERAPEUTICS INC shareholders